Discovery of novel non-peptide inhibitors of BACE-1 using virtual high-throughput screening

被引：29
作者：
Mok, N. Yi [3 ]
Chadwick, James [3 ]
Kellett, Katherine A. B. [1 ,2 ]
Hooper, Nigel M. [1 ,2 ]
Johnson, A. Peter [3 ]
Fishwick, Colin W. G. [3 ]
机构：
[1] Univ Leeds, Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England
[2] Univ Leeds, Leeds Inst Genet Hlth & Therapeut, Leeds LS2 9JT, W Yorkshire, England
[3] Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2009年 / 19卷 / 23期
关键词：
Alzheimer's disease; beta-Secretase; BACE-1; Virtual high-throughput screening; eHiTS; BETA-SECRETASE INHIBITORS; ALZHEIMERS-DISEASE; EFFICIENCY; PROGRESS; DOCKING; EHITS;
D O I：
10.1016/j.bmcl.2009.09.103
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A novel series of isatin-based inhibitors of beta-secretase (BACE-1) have been identified using a virtual high-throughput screening approach. Structure-activity relationship studies revealed structural features important for inhibition. Docking studies suggest these inhibitors may bind within the BACE-1 active site through H-bonding interactions involving the catalytic aspartate residues. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码：6770 / 6774
页数：5
相关论文
共 23 条
  • [1] The epindoline group Part I Trial of various methods for the synthesis of epindolidiones
    Ainley, AD
    Robinson, R
    [J]. JOURNAL OF THE CHEMICAL SOCIETY, 1934, : 1508 - 1520
  • [2] Isatin 3-benzoylhydrazone: A monoclinic form
    Ali, HM
    Halim, SNA
    Ng, SW
    [J]. ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2005, 61 : O3285 - O3286
  • [3] FLUORESCENT REAGENTS - ACYL CHLORIDES AND ACYL HYDRAZIDES
    BAKER, W
    HAKSAR, CN
    MCOMIE, JFW
    [J]. JOURNAL OF THE CHEMICAL SOCIETY, 1950, (JAN): : 170 - 173
  • [4] AN IMPROVED METHOD OF NITRATING AROMATIC ORTHO-HYDROXY-CARBOXYLIC ACIDS AND THEIR ESTERS
    BARANY, HC
    PIANKA, M
    [J]. JOURNAL OF THE CHEMICAL SOCIETY, 1946, (OCT): : 965 - 966
  • [5] β-Secretase inhibition for the treatment of Alzheimer's disease -: promise and challenge
    Citron, M
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (02) : 92 - 97
  • [6] BACE1 structure and function in health and Alzheimer's disease
    Cole, Sarah L.
    Vassar, Roger
    [J]. CURRENT ALZHEIMER RESEARCH, 2008, 5 (02) : 100 - 120
  • [7] Aspartic proteases in drug discovery
    Eder, Joerg
    Hommel, Ulrich
    Cumin, Frederic
    Martoglio, Bruno
    Gerhartz, Bernd
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (03) : 271 - 285
  • [8] Application of fragment-based lead generation to the discovery of novel, cyclic amidine β-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency
    Edwards, Philip D.
    Albert, Jeffrey S.
    Sylvester, Mark
    Aharony, David
    Andisik, Donald
    Callaghan, Owen
    Campbell, James B.
    Carr, Robin A.
    Chessari, Gianni
    Congreve, Miles
    Frederickson, Martyn
    Folmer, Rutger H. A.
    Geschwindner, Stefan
    Koether, Gerard
    Kolmodin, Karin
    Krumrine, Jennifer
    Mauger, Russell C.
    Murray, Christopher W.
    Olsson, Lise-Lotte
    Patel, Sahil
    Spear, Nate
    Tian, Gaochao
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (24) : 5912 - 5925
  • [9] Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
    Hardy, J
    Selkoe, DJ
    [J]. SCIENCE, 2002, 297 (5580) : 353 - 356
  • [10] Structure and Modeling in the Design of β- and γ-Secretase Inhibitors
    Holloway, M. Katharine
    Hunt, Peter
    McGaughey, Georgia B.
    [J]. DRUG DEVELOPMENT RESEARCH, 2009, 70 (02) : 70 - 93
123